Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders −1
0new positions
1sold out
$0.21avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Clear Street LLC ($14K), Warberg Asset Management LLC ($2K) and UBS Group AG ($582).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $7K |
All 13F filers, Q4 2024 → Q1 2025: 2,847 shares bought and 30,647 shares sold, net −27,800 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Clear Street LLC | — | Add +0.1% | 65,759 | $14K |
| Warberg Asset Management LLC | — | Reduce -44.3% | 10,000 | $2K |
| UBS Group AG | — | Add +2922.3% | 2,841 | $582 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.